BRIEF

on VETOQUINOL (EPA:VETO)

Vetoquinol posts stable results in the first half of 2025

Stock price chart of VETOQUINOL (EPA:VETO) showing fluctuations.

Vetoquinol announced revenue of €258 million for the first half of 2025, a decrease of 1.0% at constant exchange rates compared to the previous year. However, Essential products, representing 64% of sales, saw their revenue increase by 4.2% at constant exchange rates, totaling €165 million. The company's net profit amounted to €25 million, corresponding to 9.7% of revenue.

Regionally, Europe generated €128.9 million, while Asia-Pacific grew 7.2% at constant exchange rates. The United States rebounded in the second quarter. EBITDA stood at €53 million, representing 20.4% of revenue. The company had net cash of €164 million, and current operating income reached €34.9 million, up 9.1%.

The company continues to assert its financial stability and its development strategy, despite some sales declines due to the simplification of its products.

R. H.

Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all VETOQUINOL news